about
LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exitLEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type laminsLamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma proteinThe transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progressionMolecular insights into the premature aging disease progeriaNucleo-cytoplasmic shuttling of the endonuclease ankyrin repeats and LEM domain-containing protein 1 (Ankle1) is mediated by canonical nuclear export- and nuclear import signalsLamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biologyDegradation-mediated protein quality control at the inner nuclear membraneThe endonuclease Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivoThe inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelopeDeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cellsLAP2alpha and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assemblyThe GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse HematopoiesisMonoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482WLamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice.Lamin-binding ProteinsNucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation.Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.Breaking and making of the nuclear envelope.Proliferation of progeria cells is enhanced by lamina-associated polypeptide 2α (LAP2α) through expression of extracellular matrix proteinsEditor's Corner.A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?A-type lamin networks in light of laminopathic diseases.The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections.Barrier-to-autointegration factor--a BAFfling little protein.Proteins that associate with lamins: many faces, many functions.Lamins and lamin-associated proteins in aging and disease.141st ENMC International Workshop inaugural meeting of the EURO-Laminopathies project "Nuclear Envelope-linked Rare Human Diseases: From Molecular Pathophysiology towards Clinical Applications", 10-12 March 2006, Naarden, The Netherlands.High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization.Barrier-to-autointegration factor (BAF) involvement in prelamin A-related chromatin organization changes.Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2α.Evolvement of LEM proteins as chromatin tethers at the nuclear peripheryLamina-associated polypeptide (LAP)2α and nucleoplasmic lamins in adult stem cell regulation and disease.Lamins at the crossroads of mechanosignalingLamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation.Lamins in the nuclear interior - life outside the lamina.A-type lamins bind both hetero- and euchromatin, the latter being regulated by lamina-associated polypeptide 2 alpha.Lamina-associated polypeptide 2alpha regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway.Nucleoplasmic LAP2alpha-lamin A complexes are required to maintain a proliferative state in human fibroblasts.beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
P50
Q24295870-D18B319A-19A6-4176-AAF5-5D71A531733DQ24298515-04C0778E-A001-46F4-8D55-FB7B591409AEQ24541561-B4BED32C-32C9-4BAB-9FFC-BEF8C59BEF91Q24609844-86F6DA48-D753-4EC5-B11B-111EA6898B33Q26768972-A22B04CD-8C65-49FE-9526-EB89368247D0Q27318643-CFB65A69-DDC5-47A4-B4DE-8D8779493E50Q27687804-B2FE4ADF-FC17-4B6C-9008-BFA405ABEE27Q28066166-40C3F3FF-F688-45B9-BDDD-FAD8A78A8EEEQ28115809-39AB95B2-E902-468B-AF2F-541514D2DC7CQ28265573-0579B613-3DA9-415D-81C4-E193793A16ECQ28304564-EA60643F-4A74-4B8D-8DD8-A61FCEDB9438Q28567116-7AB5F4A0-4509-4F46-9B51-3C3BF8026318Q28592466-EB802ED5-24C7-448B-9478-387F4041D678Q28752198-6B578D0D-A8CD-4154-891A-6AB7932293FCQ33639577-F0D1D8B3-1430-4FCA-B08D-03CB2B5C1532Q33752204-1A09E2EA-2448-48E3-9F70-F41E7AA0F347Q34654052-7D361CB2-CC98-44DC-A18F-715E7476EF0CQ35620884-A221F7A8-F27E-4478-A276-9E8B93C98FEEQ36098925-06E42760-E1BB-49F8-9039-0BE71AA668C2Q36158116-B42AD1B6-0B65-4349-A054-4920AEB24A91Q36189773-30F82F9F-E2B3-4E93-90A3-E5294A3A86D5Q36249005-11B6923C-BA28-40BC-AB44-B9C74220EF62Q36578307-15033F8E-6F4F-4BF1-8EF5-C28F6D16B9F4Q36673184-74F36878-8875-4B3D-8E45-3DE1F64D9BBFQ36744361-E764981B-3B7B-4656-BD95-9206BA623AF0Q36798705-56D8B13A-76D0-4080-A6CC-48796185D220Q36805033-1FAAB84B-26B2-4094-BC0B-F94E1BF6C0B1Q36857590-2895EE18-DE8B-4205-8E1D-9D45FD777F5CQ36947756-A3ED2CCB-BDAD-4B7D-A938-F1504794A7E3Q37085852-EE255565-B03F-4F09-AD56-D0E38DCB727CQ37463359-FB5474B6-CC55-44D5-B827-E29874F6EE50Q37958966-4259070C-C1C5-426B-828D-3ED0E8D06E86Q38174396-D41F28E4-E96A-4D9E-90FF-D7CD1636603AQ38341565-ECBDBDA1-C223-475E-9812-3D189BA08C98Q38369407-97A12937-D80B-409A-9B58-3EB3D2201AE5Q38698252-D1A24131-1F70-41D8-9EEC-AE5A536B52BBQ38800544-5A879943-404B-43CB-A8B9-6B7BD45BE2F8Q39727080-A43FDFF8-FDF5-4EAA-802C-66DA0F1C1BE5Q39731192-452DF6DA-B4B9-41DA-BD93-1524A3B9EE60Q40593741-76FC0803-6F78-4319-B829-E5DCF78F69B0
P50
name
Roland Foisner
@en
type
label
Roland Foisner
@en
prefLabel
Roland Foisner
@en